Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Metolachlor

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Longhorn Vaccines to Present Data on Universal Influenza Candidate
    Longhorn Vaccines to Present Data on Universal Influenza Candidate

    09 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250409981446/en/Longhorn-Vaccines-and-Diagnostics-to-Present-Data-on-Single-and-Dual-Peptide-Universal-Influenza-Candidates-at-ESCMID-2025

    BUSINESSWIRE
    09 Apr 2025
    Share Share
    Kairos Pharma Participates in Scientific and Industry Events
    Kairos Pharma Participates in Scientific and Industry Events

    27 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250327798514/en/Kairos-Pharma-Ltd.-Highlights-Participation-in-Recent-and-Upcoming-Scientific-and-Industry-Events

    BUSINESSWIRE
    27 Mar 2025
    Share Share
    Vast Granted FDA Infectious Disease Designation
    Vast Granted FDA Infectious Disease Designation

    25 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vast-granted-qualified-infectious-disease-product-designation-from-the-fda-302411166.html

    PR NEWSWIRE
    25 Mar 2025
    Share Share
    Galderma Places EUR 500M Eurobond and CHF 435M CHF Bonds
    Galderma Places EUR 500M Eurobond and CHF 435M CHF Bonds

    14 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250313561475/en/Galderma-Successfully-Placed-an-Inaugural-EUR-500-Million-Single-Tranche-Eurobond-and-New-Dual-Tranche-CHF-435-Million-CHF-Bonds

    BUSINESSWIRE
    14 Mar 2025
    Share Share
    SpliceBio Doses First Patient in Phase 1/2 ASTRA Study of SB-007
    SpliceBio Doses First Patient in Phase 1/2 ASTRA Study of SB-007

    13 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/splicebio-announces-first-patient-dosed-in-phase-12-astra-study-of-sb-007-a-dual-aav-gene-therapy-for-stargardt-disease-302400963.html

    PR NEWSWIRE
    13 Mar 2025
    Share Share
    Pennant Reports Fourth Quarter and Fiscal Year 2024 Results
    Pennant Reports Fourth Quarter and Fiscal Year 2024 Results

    27 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/27/3034333/0/en/Pennant-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Results.html

    GLOBENEWSWIRE
    27 Feb 2025
    Share Share